Gilead extends Arcellx tender offer expiration date
Source: SeekingAlpha
2026-04-01 16:31:12 ET
More on Gilead Sciences
- Gilead Sciences, Inc. (GILD) M&A Call Transcript
- Gilead Sciences: Caution After A Re-Rating Amidst New Concentration Risks
- Gilead: Why The 'Immune System Company' Pivot Is No Longer A Bargain (Downgrade)
- Galapagos NV, Gilead Sciences strike deal tied to Ouro Medicines acquisition
- Gilead to acquire Ouro Medicines in $1.68B deal to advance autoimmune T cell therapies
Read the full article on Seeking Alpha
For further details see:
Gilead extends Arcellx tender offer expiration date
Arcellx Inc.
NASDAQ: ACLX
ACLX Trading
0.04% G/L:
$115.08 Last:
1,195,659 Volume:
$115.04 Open:
ACLX Latest News
March 16, 2026 07:33:01 pm
This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal
ACLX Stock Data
$3,888,009,846
37,694,730
1.62%
80
N/A
Biotechnology & Life Sciences
Healthcare
US
Redwood City
